Matthias Meier - Novartis Pharmaceutical AG

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

BAYESIAN DYNAMIC BORROWING APPROACH FOR APPARENT PHASE 3 STUDY OF IPTACOPAN IN ICMPGN

Andrew Bomhack, David Kavanagh,Marina Vivarelli,Yaqin Wang,UdayKiran Veldandi,Nicholas Webb,Matthias Meier,Richard Smith

AMERICAN JOURNAL OF KIDNEY DISEASESno. 4 (2024): S124-S124

引用0浏览0引用

Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy

Carla M. Nester, Ute Eisenberger, Alexandre Karras, Moglie le Quintrec, Liz Lightstone,Manuel Praga,Giuseppe Remuzzi, Maria José Soler, Junhao Liu,Matthias Meier, Ronda Tawfik,Guido Junge,Andrea Biondani,Angelo J. Trapani, Nicholas JA. Webb,Edwin KS. Wong

Kidney International Reports (2024)

引用0浏览0引用

DEVELOPING THERAPIES FOR C3G: REPORT OF THE KIDNEY HEALTH INITIATIVE C3G TRIAL ENDPOINTS WORK GROUP

Carla Nester, Dima A. Decker,Matthias Meier,Shakil Aslam,Andrew S. Bomback,Fernando Caravaca-Fontan,Terence H. Cook, David L. Feldman,Veronique Fremeaux-Bacchi,Daniel P. Gale, Ann Gooch,Sally Johnson,Christoph Licht,Mohit Mathur,Matthew C. Pickering,Manuel Praga,Giuseppe Remuzzi,Viknesh Selvarajah,Richard J. Smith,Hossein Tabriziani,Nicole van de Kar,Yaqin Wang,Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun,Howard Trachtman,Aliza Thompson

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYno. 9 (2024): 1201-1208

引用0浏览0WOS引用

Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy: 12-Month Results from the Phase 3 APPEAR-C3G Study

Carla M. Nester, Richard J. Smith,David Kavanagh,Marina Vivarelli,Giuseppe Remuzzi,Ming-Hui Zhao,Edwin Kwan Soon Wong, Yaqin Wang,Angelo J. Trapani, Induja Krishnan, Nicholas J. Webb,Matthias Meier,Andrew S. Bomback

Journal of the American Society of Nephrologyno. 10S (2024)

引用0浏览0引用

#277 Update to the Long-Term Safety and Efficacy of Iptacopan in C3G: 33-Month Extension Study Data from Patients Enrolled in a Phase 2 Study

Carla M Nester,Ute Eisenberger,Alexandre Karras,Moglie Le Quintrec,Liz Lightstone,Manuel Praga,Giuseppe Remuzzi,Maria José Soler Romeo,Junhao Liu,Matthias Meier,Nicholas Webb,Edwin Wong

Nephrology Dialysis Transplantationno. Supplement_1 (2024)

引用0浏览0引用

Experience with Iptacopan in Patients with Recurrent Complement 3 Glomerulopathy (C3G): Early Access Program Data

Serge Smeets, Soudeh Ansari, Sviatlana Rizk, Induja Krishnan, Nicholas J. Webb,Matthias Meier

Journal of the American Society of Nephrologyno. 10S (2024)

引用0浏览0引用

Update to the Long-Term Safety and Efficacy of Iptacopan in C3G: 33-Month Extension Study Data from Patients Enrolled in a Phase 2 Study

Carla M. Nester,Ute Eisenberger,Alexandre Karras,Moglie Le Quintrec,Liz Lightstone,Manuel Praga,Giuseppe Remuzzi,Maria Jose Soler Romeo, Junhao Liu,Matthias Meier,Nicholas Webb,Edwin Wong

NEPHROLOGY DIALYSIS TRANSPLANTATION (2024): I254-I254

引用0浏览0引用

WCN24-1146 SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

Nicholas Webb,David Kavanagh,Andrew S. Bomback,Richard J.H. Smith,UdayKiran Veldandi,Yaqin Wang,Matthias Meier,Marina Vivarelli

Kidney International Reportsno. 4 (2024): S116-S117

引用0浏览0引用

Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study

Marina Vivarelli,Andrew S. Bomback,Matthias Meier,Yaqin Wang,Nicholas J. A. Webb,Uday Kiran Veldandi,Richard J. H. Smith,David Kavanagh

Kidney International Reportsno. 1 (2023): 64-72

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn